BN Business News
أضف شركتك →
تجري حاليًا ترجمة هذا المقال. نعرض مؤقتًا النسخة الأصلية باللغة الإنجليزية.

الطاقة والبيئة · 26‏/4‏/19941 دقائق للقراءة

Rulemaking for the Pharmaceuticals Manufacturing Industry Notice of Public Meeting

ترجمة آلية محلية · اللغة الأصلية للمصدر

الملخص

The U.S. Environmental Protection Agency (EPA) is developing regulations that will apply to the pharmaceuticals manufacturing industry. The regulations are scheduled to be proposed in August 1994, and EPA is sponsoring a public meeting prior to proposal. EPA is developing effluent limitations guidelines and standards under authority of the clean Water Act. The Agency plans to proceed with this rulemaking and coordinate this effort with the development of maximum achievable control technology standards under authority of the Clean Water Act. These standards are due to be developed on a separate schedule. The public meeting is intended to be a forum in which EPA can report on the status of regulatory development and in which interested parties can provide information and ideas on key technical, scientific, and other issues. Other agenda topics for this public meeting include a summary of data collection activities, options development and preliminary technology-based options selection. A document relating to the above topics and a more detailed agenda will be available at the meeting.

اللغة الأصلية للمصدر: Federal Register — Environmental Protection Agencyافتح البيان الأصلي →

استكشف الموضوعات

تحليلات الأعمال →